Founders Capital Management Volitionrx LTD Transaction History
Founders Capital Management
- $154 Million
- Q1 2025
A detailed history of Founders Capital Management transactions in Volitionrx LTD stock. As of the latest transaction made, Founders Capital Management holds 2,000 shares of VNRX stock, worth $980. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$980
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VNRX
# of Institutions
31Shares Held
18.9MCall Options Held
21KPut Options Held
0-
Armistice Capital, LLC New York, NY8.48MShares$4.16 Million0.07% of portfolio
-
Lagoda Investment Management, L.P. New York, NY7.58MShares$3.71 Million2.46% of portfolio
-
Geode Capital Management, LLC Boston, MA744KShares$364,4830.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA637KShares$311,9660.0% of portfolio
-
Black Rock Inc. New York, NY516KShares$252,8750.0% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $28.1M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...